Stefan Anker

Stefan Anker has bridged cardiac cachexia and cancer cachexia, demonstrating shared inflammatory and neuroendocrine mechanisms. His research on TNF-alpha, IL-6, and the renin-angiotensin-aldosterone system in cachexia has informed therapeutic targeting strategies. He established that cachexia is a systemic syndrome extending beyond muscle to cardiac, metabolic, and immune systems, and has contributed to clinical staging frameworks for both cardiac and cancer cachexia.